The Long Road to FDA Approval of Plinabulin and G-CSF to Prevent Chemotherapy Induced Neutropenia

BeyondSpring Pharmaceuticals has issued a press release announcing that the FDA presented the company with a complete response letter pertaining to its drug plinabulin and granulocyte colony-stimulating factor (G-CSF). The…

Continue Reading The Long Road to FDA Approval of Plinabulin and G-CSF to Prevent Chemotherapy Induced Neutropenia
INFILTR8: A New and Rare Genetic Disease
source: pixabay.com

INFILTR8: A New and Rare Genetic Disease

  Pursuing an education can be difficult enough without any other extraneous factors. But what if you were also battling frequent infections, gastrointestinal problems, and recurrent hospitalizations? For Evan Brandon,…

Continue Reading INFILTR8: A New and Rare Genetic Disease
Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity
https://pixabay.com/en/baby-girl-sleep-child-toddler-1151351/

Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity

Orphan Drug designation is typically granted to drugs or biologics intended to treat, prevent, or diagnose rare diseases; in the United States, these are conditions affecting under 200,000 Americans. Drug…

Continue Reading Xywav for Idiopathic Hypersomnia Earns Orphan Drug Exclusivity